Search Within

David Hoyos

Formats
  1. Journal Article (9)
  2. Meeting Abstract (4)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Center for Pancreatic Cancer Research (15)
  2. Computational Oncology Service (15)
  3. Epidemiology and Biostatistics (15)
  4. GSK Faculty (15)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (10)
  6. Department of Medicine (9)

More Groups

People
  1. Benjamin Greenbaum (15)
  2. Jayon Lihm (5)
  3. Vinod Balachandran (5)
  4. Zachary Sethna (5)
  5. Alvin Makohon-Moore (4)
  6. Christine Iacobuzio-Donahue (4)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2022 (7)
  4. 2021 (4)
  5. 2020 (2)
Publications
  1. Nature (3)
  2. Cancer Research (2)
  3. Clinical Cancer Research (2)
  4. Annals of Oncology (1)
  5. Cancer Discovery (1)
  6. Cell Death and Differentiation (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. Nature Publishing Group (5)
  3. American Association for the Advancement of Science (1)
  4. Biomed Central Ltd (1)
  5. Nature Research (1)
  6. Oxford University Press (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
    Journal Article

    Solovyov, A.; Behr, J. M.; Hoyos, D.; Banks, E.; Drong, A. W.; Thornlow, B.; Zhong, J. Z.; Garcia-Rivera, E.; McKerrow, W.; Chu, C.; more...
    Nature Communications (2025)

    Fulltext@MSK | Save
  • Structures, functions and adaptations of the human LINE-1 ORF2 protein
    Journal Article

    Baldwin, E. T.; van Eeuwen, T.; Hoyos, D.; Zalevsky, A.; Tchesnokov, E. P.; Sánchez, R.; Miller, B. D.; Di Stefano, L. H.; Ruiz, F. X.; Hancock, M.; more...
    Nature (2024)

    Fulltext@MSK | Save
  • Perfecting antigen prediction
    Editorial

    Hoyos, D.; Greenbaum, B. D.
    Journal of Experimental Medicine (2022)

    Fulltext@MSK | Save
  • Systemic and oligo-acquired resistance to PD-(L)1 blockade in lung cancer
    Journal Article

    Schoenfeld, A. J.; Rizvi, H. A.; Memon, D.; Shaverdian, N.; Bott, M. J.; Sauter, J. L.; Tsai, C. J.; Lihm, J.; Hoyos, D.; Plodkowski, A. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Journal Article

    Łuksza, M.; Sethna, Z. M.; Rojas, L. A.; Lihm, J.; Bravi, B.; Elhanati, Y.; Soares, K.; Amisaki, M.; Dobrin, A.; Hoyos, D.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Fundamental immune–oncogenicity trade-offs define driver mutation fitness
    Journal Article

    Hoyos, D.; Zappasodi, R.; Schulze, I.; Sethna, Z.; de Andrade, K. C.; Bajorin, D. F.; Bandlamudi, C.; Callahan, M. K.; Funt, S. A.; Hadrup, S. R.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
    Journal Article

    Gigoux, M.; Holmström, M. O.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • The genotypes and phenotypes of missense mutations in the proline domain of the p53 protein
    Review

    Hoyos, D.; Greenbaum, B.; Levine, A. J.
    Cell Death and Differentiation (2022)

    Fulltext@MSK | Save
  • Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies
    Journal Article

    Lee, C. Y.; Shah, M. K.; Hoyos, D.; Solovyov, A.; Douglas, M.; Taur, Y.; Maslak, P.; Babady, N. E.; Greenbaum, B.; Kamboj, M.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Sethna, Z.; Luksza, M.; Rojas, L.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save